· rebuilt nightly from public records
Signal Sheet
Indaptus Therapeutics is a publicly listed pharmaceutical preparations company in New York, New York, founded 2021. It raised $2.3M in Jun 2025 and its filings name 15 officers. Everything below links to the record it came from.
The easy button for new customers
Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.
Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.
The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names
| Role | Contact | Source | Why they matter now |
|---|---|---|---|
| Executive Officer | Jeffrey A. Meckler | SEC filing, Jun 2025 | Named officer in the filing; part of the buying group |
| Executive Officer | Michael J Newman | SEC filing, Jun 2025 | Named officer in the filing; part of the buying group |
| Executive Officer | Nir Sassi | SEC filing, Jun 2025 | Named officer in the filing; part of the buying group |
| Executive Officer | Walt A. Linscott | SEC filing, Jun 2025 | Named officer in the filing; part of the buying group |
| Executive Officer | Roger J. Waltzman | SEC filing, Jun 2025 | Named officer in the filing; part of the buying group |
| Executive Officer | Walt A Linscott | SEC filing, Jan 2025 | Named officer in the filing; part of the buying group |
| Executive Officer | Michael J. Newman | SEC filing, Jan 2025 | Named officer in the filing; part of the buying group |
| Executive Officer | Roger Waltzman | SEC filing, Jan 2025 | Named officer in the filing; part of the buying group |
| Chief Technology Officer | Roger J. Pomerantz | SEC filing, Jun 2025 | Technology and tooling decisions |
| Chief Technology Officer | Hila Karah | SEC filing, Jun 2025 | Technology and tooling decisions |
| Chief Technology Officer | Anthony J. Maddaluna | SEC filing, Jun 2025 | Technology and tooling decisions |
| Chief Technology Officer | William B. Hayes | SEC filing, Jun 2025 | Technology and tooling decisions |
| Chief Technology Officer | Mark J. Gilbert | SEC filing, Jun 2025 | Technology and tooling decisions |
| Chief Technology Officer | Robert E. Martell | SEC filing, Jun 2025 | Technology and tooling decisions |
| Chief Technology Officer | Mark J Gilbert | SEC filing, Jan 2025 | Technology and tooling decisions |
Signed a material agreement
Corporate eventOfficer or director change
New leadershipEquity raise reported to the SEC, Jun 2025. Money arrives before the spending plan does.
CapitalThe most recent events first, refreshed every night. Each links to the record it came from.
| When | What happened | Kind | Source |
|---|---|---|---|
| Sep 29, 2026 | Signed a material agreement | Corporate event | SEC filing |
| Sep 8, 2026 | Signed a material agreement | Corporate event | SEC filing |
| Sep 2, 2026 | Officer or director change | New leadership | SEC filing |
| Aug 28, 2026 | Signed a material agreement | Corporate event | SEC filing |
| Aug 28, 2026 | Signed a material agreement | Corporate event | SEC filing |
| Jun 12, 2025 | Raised $2.3M in equity from 20 investors | Capital | SEC filing |
| Jan 16, 2025 | Raised $2.2M in equity from 16 investors | Capital | SEC filing |
| Nov 22, 2024 | Raised $227K in equity from 20 investors | Capital | SEC filing |
Lakewave finds the right people at Indaptus Therapeutics, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.
Try it on Indaptus Therapeutics with a free trial →| Headquarters | New York, New York, per the filing address |
| Industry group | Pharmaceutical Preparations |
| Founded | 2021, DE |
| Ownership | Listed company |
| Raise history | $227K (Nov 2024) · $2.2M (Jan 2025) · $2.3M (Jun 2025) |
Private-sector companies in the same industry group and state, ranked by Rising score.
Yes. Indaptus Therapeutics reported a $2.3M equity raise to the SEC on Jun 12, 2025 with 20 investors.
The company's SEC filing, Jun 2025 names Jeffrey A. Meckler (Executive Officer) among its officers.
New York, New York, per the address on its SEC filing.
Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.
Start your free trialCompiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.